Clinical efficacy of recombinant gonadotrophins

Author： Balen Adam H.   Hayden Catherine J.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.14, Iss.6, 1999-06, pp. : 1411-1417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

ESHRE. The clinical benefits of recombinant gonadotrophins

By  

Human Reproduction, Vol. 15, Iss. 3, 2000-03 ,pp. : 734-735

Oxford University Press

Access to resources Recommend Favorite

What are the clinical benefits of recombinant gonadotrophins?

By Out Henk J.  

Human Reproduction, Vol. 14, Iss. 9, 1999-09 ,pp. : 2189-2190

Oxford University Press

Access to resources Recommend Favorite

Prions, urinary gonadotrophins and recombinant gonadotrophins

By Matorras Roberto   Rodríguez‐Escudero Francisco Javier  

Human Reproduction, Vol. 18, Iss. 5, 2003-05 ,pp. : 1129-1130

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized study to assess the clinical efficacy of gonadotrophins administered subcutaneously and intramuscularly

By Engmann L   Shaker A   White E   Bekir JS   Jacobs HS   Tan SL  

Human Reproduction, Vol. 13, Iss. 4, 1998-04 ,pp. : 836-840

Oxford University Press

Access to resources Recommend Favorite

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients

By Jansen CAM  

Human Reproduction, Vol. 13, Iss. 11, 1998-11 ,pp. : 2995-2999

Oxford University Press

Access to resources Recommend Favorite